Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit Protein Stimulus Other Stimulus Stimulus Concentration Stimulus Conc Unit ExpPlate Measured Protein Measured Protein MFI (a.u.) Bead Count
N2645 IKK16 2.0
uM
 TNF-a 100
ng/mL
 2
RANTES
 1338.0 58
RA2708 5z-7-oxozeaenol 0.6
uM
 TNF-a 100
ng/mL
 2
RANTES
 81.0 84
RA2708 IKK16 2.0
uM
 TNF-a 100
ng/mL
 2
RANTES
 4770.5 68
RA2159 Tofacitinib 0.3
uM
 TNF-a 100
ng/mL
 2
RANTES
 22830.0 49
RA2159 TNF-a 100
ng/mL
 2
RANTES
 25273.0 51
N2645 Tofacitinib 0.3
uM
 TNF-a 100
ng/mL
 2
RANTES
 17351.0 55
N2645 TNF-a 100
ng/mL
 2
RANTES
 19006.0 72
RA2708 Tofacitinib 0.3
uM
 TNF-a 100
ng/mL
 2
RANTES
 21015.0 46
RA2708 TNF-a 100
ng/mL
 2
RANTES
 19634.0 49
RA2159 5z-7-oxozeaenol 0.6
uM
 IL-1 alpha 100
ng/mL
 2
RANTES
 55.0 71
RA2159 IKK16 2.0
uM
 IL-1 alpha 100
ng/mL
 2
RANTES
 1069.5 78
N2645 5z-7-oxozeaenol 0.6
uM
 IL-1 alpha 100
ng/mL
 2
RANTES
 39.5 64
N2645 IKK16 2.0
uM
 IL-1 alpha 100
ng/mL
 2
RANTES
 374.0 53
RA2708 5z-7-oxozeaenol 0.6
uM
 IL-1 alpha 100
ng/mL
 2
RANTES
 34.0 67
RA2708 IKK16 2.0
uM
 IL-1 alpha 100
ng/mL
 2
RANTES
 594.0 51
RA2159 Tofacitinib 0.3
uM
 IL-1 alpha 100
ng/mL
 2
RANTES
 11121.0 52
RA2159 IL-1 alpha 100
ng/mL
 2
RANTES
 10200.0 78
N2645 Tofacitinib 0.3
uM
 IL-1 alpha 100
ng/mL
 2
RANTES
 5270.0 63
N2645 IL-1 alpha 100
ng/mL
 2
RANTES
 7443.5 52
RA2708 Tofacitinib 0.3
uM
 IL-1 alpha 100
ng/mL
 2
RANTES
 5867.0 61
RA2708 IL-1 alpha 100
ng/mL
 2
RANTES
 5605.0 55
RA2159 5z-7-oxozeaenol 0.6
uM
 Poly(I:C) 2
ug/mL
 2
RANTES
 1015.5 78
RA2159 IKK16 2.0
uM
 Poly(I:C) 2
ug/mL
 2
RANTES
 4276.5 72
N2645 5z-7-oxozeaenol 0.6
uM
 Poly(I:C) 2
ug/mL
 2
RANTES
 168.0 78
N2645 IKK16 2.0
uM
 Poly(I:C) 2
ug/mL
 2
RANTES
 208.0 71